For more information or confidential assistance
Call 800-306-3180

Arizona Plaintiffs File Joint Actos Lawsuit

Actos Prescription Drug
A number of plaintiffs from Tucson, AZ have filed a joint Actos lawsuit against Takeda Pharmaceuticals. Their lawsuit will join thousands currently pending under multidistrict litigation in the U.S. District Court for the Western District of Louisiana. Garry and Ruth Buchman are among the group... Read More

Takeda Reaches $2.4 Billion Actos Settlement

Takeda Pharmaceuticals has agreed to a $2.4 billion Actos settlement that would largely resolve thousands of claims regarding the drug’s risk of bladder cancer. The company said that the settlement would go into effect if at least 95% of current plaintiffs accept it; in this... Read More

FDA Advisory Panel: Onglyza Could Raise Heart Failure Risk

Periodically, the U.S. Food and Drug Administration (FDA) requests reviews of medications to determine if they present a potential safety risk. Diabetes medications in particular have proven problematic because of potential complications. These include a possible risk of bladder cancer for those taking Actos, and... Read More

Takeda Offers $2.2 Billion Actos Settlement

Actos
Takeda Pharmaceuticals, manufacturer of Actos, is willing to pay $2.2 billion to resolve claims that it concealed cancer risks linked to its diabetes medicine. The proposed Actos settlement, if accepted by plaintiffs, would mark one of the largest U.S. accords of patient lawsuits involving pharmaceutical... Read More

Actos Bladder Cancer Lawsuit Filed by 17 Plaintiffs

Actos lawsuit news
Seventeen plaintiffs have filed an Actos bladder cancer lawsuit against manufacturer Takeda Pharmaceuticals, claiming use of the type 2 diabetes treatment led to the diagnosis of bladder cancer. Four of the plaintiffs filed their complaint on behalf of family members that died after their bladder... Read More

Three Case Management Orders Entered in Actos MDL

Actos lawsuit news
There are currently more than 3500 Actos lawsuits centralized in the Western District of Louisiana in MDL: 2299 (In Re: Actos (Pioglitazone) Products Liability Litigation) before United States Magistrate Judge Hanna Doherty. In addition, Takeda Pharmaceuticals, the manufacturer of Actos, the diabetes medication, faces 4500... Read More

Jury Finds Takeda Intentionally Destroyed Actos Files

Actos lawsuit news
A lawsuit that alleges the drug Actos causes bladder cancer has resulted in a bittersweet verdict for the plaintiff, Richard Myers, a retired bakery worker. Although the jury concluded that Takeda Pharmaceuticals must pay $155,000 for destroying documents crucial to numerous lawsuits, Myers could have... Read More

Takeda & Eli Lilly Get a Reprieve in Actos Lawsuit Award

Actos lawsuit news
Takeda Pharmaceutical Co. and Eli Lilly & Co. won a partial but sizable reprieve from their $9 billion punitive damages Actos verdict in the Louisiana case of Terence Allen v. Takeda Pharmaceuticals North America Inc. Mr. Allen, a former hardware store manager from Attica, NY, alleged... Read More